- Hims & Hers falls 8% as FDA issues warning letter over compounded weight loss drug Seeking Alpha
- FDA takes aim at Hims and other telehealth services in drug advertising blitz AP News
- Hims & Hers Stock: How It Found Itself in the FDA’s Crosshairs Barron’s
- Opinion | I Run the F.D.A. Pharma Ads Are Hurting Americans. The New York Times
- Trump’s drug ad crackdown may get a reality check Axios
Source link
